Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InterCure Ltd. (INCR : NSDQ)

• Company Description    InterCure is a cannabis company. It is a licensed cannabis producer which offer good manufacturing practices certified and pharmaceutical-grade medical cannabis products. InterCure is based in NEW YORK. Number of Employees: 350

• Price / Volume Information    Yesterday's Closing Price: $7.23 Daily Weekly Monthly 20 Day Moving Average: 110,409 shares Shares Outstanding: 42.74 (millions) Market Capitalization: $308.97 (millions) Beta: 52 Week High: $8.77 52 Week Low: $4.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 17.94% 32.83% 12 Week 15.86% 27.37% Year To Date 11.57% 37.08%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 85 MEDINAT HA-YEHUDIM STREET - HERZLIYA,L3 4676670 ISR ph: 972-77-460-5012 fax: - None http://www.intercure.co

• General Corporate Information    Officers Alexander Rabinovich - Chief Executive Officer Ehud Barak - Chairman Amos Cohen - Chief Financial Officer David Salton - Director Alon Granot - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: M549GJ111 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 09/07/22 Share - Related Items Shares Outstanding: 42.74 Most Recent Split Date: (:1) Beta: Market Capitalization: $308.97 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/07/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 60.25 PEG Ratio: - Price Ratios Price/Book: 2.17 Price/Cash Flow: 82.61 Price / Sales: 3.61 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 650.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 8.05% ROE 03/31/22 - 3.30 12/31/21 - - 09/30/21 - - ROA 03/31/22 - 2.31 12/31/21 - - 09/30/21 - - Current Ratio 03/31/22 - - 12/31/21 - 1.74 09/30/21 - 1.90 Quick Ratio 03/31/22 - - 12/31/21 - 1.39 09/30/21 - 1.58 Operating Margin 03/31/22 - 5.38 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - 5.38 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - 8.28 09/30/21 - - Book Value 03/31/22 - - 12/31/21 - 3.33 09/30/21 - 3.26 Inventory Turnover 03/31/22 - - 12/31/21 - 2.49 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - 0.07 09/30/21 - 0.05 Debt-to-Capital 03/31/22 - - 12/31/21 - 6.77 09/30/21 - 5.16

Powered by Zacks Investment Research ©